Teva Pharma Industries Stock Price on April 22, 2025
TEVA Stock | USD 16.19 0.57 3.65% |
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. As of today, the current price of Teva Pharma stands at 16.19, as last reported on the 3rd of May, with the highest price reaching 16.36 and the lowest price hitting 15.74 during the day. Teva Pharma Industries owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0241, which indicates the firm had a -0.0241 % return per unit of risk over the last 3 months. Teva Pharma Industries exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Teva Pharma's Variance of 8.12, coefficient of variation of (1,727), and Risk Adjusted Performance of (0.09) to confirm the risk estimate we provide. At present, Teva Pharma's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 24.9 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 789 M. . At present, Teva Pharma's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Cash Flow Ratio is expected to grow to 26.00, whereas Price To Sales Ratio is forecasted to decline to 1.45. Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 3.3109 | Enterprise Value Ebitda 41.3556 | Price Sales 1.0829 | Shares Float 1.1 B | Wall Street Target Price 22.3838 |
Teva Pharma Main Headline on 22nd of April 2025
300,000 Shares in Teva Pharmaceutical Industries Limited Bou... by thelincolnianonline.com
Diadema Partners LP acquired a new stake in shares of Teva Pharmaceutical Industries Limited in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 300,000 shares of the companys stock, valued at approximately 6,677,000. Teva Pharmaceutical Industries comprises 2.8 percent of Diadema
Teva Pharma Valuation on April 22, 2025
It is possible to determine the worth of Teva Pharma on a given historical date. On April 22, 2025 Teva was worth 13.8 at the beginning of the trading date compared to the closed value of 14.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Teva Pharma stock. Still, in general, we apply an absolute valuation method to find Teva Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Teva Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Teva Pharma's related companies.
Open | High | Low | Close | Volume | |
13.46 | 13.46 | 13.04 | 13.31 | 12,058,651 | |
04/22/2025 | 13.80 | 14.07 | 13.61 | 14.00 | 12,002,319 |
14.33 | 14.61 | 14.21 | 14.29 | 10,702,315 |
Backtest Teva Pharma | | | Teva Pharma History | | | Teva Pharma Valuation | Previous | Next |
Teva Pharma Trading Date Momentum on April 22, 2025
On April 23 2025 Teva Pharma Industries was traded for 14.29 at the closing time. The top price for the day was 14.61 and the lowest listed price was 14.21 . The trading volume for the day was 10.7 M. The trading history from April 23, 2025 was a factor to the next trading day price jump. The trading price change against the next closing price was 2.07% . The trading price change against the current closing price is 12.93% . |
Teva Pharma Industries Fundamentals Correlations and Trends
By evaluating Teva Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Teva Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Teva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Teva Pharma Stock history
Teva Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharma Industries will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharma stock prices may prove useful in developing a viable investing in Teva Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 1.1 B | 789 M | |
Net Loss | -2.1 B | -2 B |
Teva Pharma Stock Technical Analysis
Teva Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Teva Pharma Period Price Range
Low | May 3, 2025
| High |
0.00 | 0.00 |
Teva Pharma Industries cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Teva Pharma May 3, 2025 Market Strength
Market strength indicators help investors to evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teva Pharma shares will generate the highest return on investment. By undertsting and applying Teva Pharma stock market strength indicators, traders can identify Teva Pharma Industries entry and exit signals to maximize returns
Teva Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Teva Pharma's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (0.06) | |||
Total Risk Alpha | 0.0256 | |||
Treynor Ratio | (0.17) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |